United States · FDA National Drug Code directory
Montelukast
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 68001-361_d9dbbe03-bcc4-1af7-e053-2a95a90a8053
- Product NDC
- 68001-361
- Form
- TABLET
- Composition / generic term
- Montelukast
- Labeler
- BluePoint Laboratories
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20180629
- Source listing expiry
- 20261231
Source-listed ingredients
- MONTELUKAST SODIUM — 10 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 500 TABLET in 1 BOTTLE (68001-361-03) · 68001-361-03
- 30 TABLET in 1 BOTTLE (68001-361-04) · 68001-361-04
- 90 TABLET in 1 BOTTLE (68001-361-05) · 68001-361-05
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →